If you need more lookups,
subscriptions start at $34 USD/month.
Tamas Agh Location
Hungary
Tamas Agh Work
Director of Strategy @ (October 2024 - Present)
Deputy Director of Strategy @ (June 2024 - October 2024)
Principal Researcher @ (January 2016 - May 2024)
Senior Researcher @ (June 2013 - December 2015)
Research Associate Professor @ University of Pécs, Center for Health Technology Assessment and Pharmacoeconomic (September 2021 - Present)
Editor in Chief @ Expert Review of Pharmacoeconomics & Outcomes Research (January 2026 - Present)
Family Physician @ Dr Agh and Partner (January 2009 - Present)
Business Analyst @ Gedeon Richter Plc (October 2011 - May 2013)
Resident @ Semmelweis University (October 2006 - December 2008)
Tamas Agh Education
Semmelweis University
PhD (Pharmacoeconomics)
2008-2012
Corvinus University
MSc (Physician-Economist)
2007-2010
Semmelweis University
Medical Doctor
1999-2006
University of Pécs Doctoral School of Health Sciences
DrHabil
2020
Semmelweis University
Specialist in Family Medicine
2010
Tamas Agh Skills
Business Analysis
Forecasting
HTA
Health Economics
Health Policy
Healthcare
Life Sciences
Market Access
Medication Adherence
Medicine
Oncology
Outcomes Research
Patient Reported Outcomes
Pharmaceutical Industry
Pharmaceutical Sales
Pharmacy
Pulmonary Diseases
Quality of Life
Research
Women's Health
Customer Service
Analysis
Hungarian
Business Development
Leadership
Sales
Public Health
Finance
Management
Analytical Skill
Development
Tamas Agh Summary
Tamas Agh, based in Hungary, is currently a Director of Strategy at Syreon Research Institute. Tamas Agh brings experience from previous roles at Syreon Research Institute and University of Pécs, Center for Health Technology Assessment and Pharmacoeconomic. Tamas Agh holds a 2008 - 2012 PhD in Pharmacoeconomics @ Semmelweis University. With a robust skill set that includes Business Analysis, Forecasting, HTA, Health Economics, Health Policy and more. Tamas Agh has 1 emails on RocketReach.
Looking for a different Tamas Agh?
Find contact details for 700 million professionals.